SCHEMBL22011103

SCHEMBL22011103

CCCCCc1ccc(-c2cc3oc4cc(CCC)c(F)c(F)c4c3c(F)c2F)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 9/20 0.42
ABCB1 P08183 1/20 0.40
RARA P10276 2/20 0.39
RARG P13631 1/20 0.39
HSD17B10 Q99714 3/20 0.36
TSHR P16473 1/20 0.36
ALDH1A1 P00352 3/20 0.35
MEN1 O00255 2/20 0.35
MAPT P10636 2/20 0.35
KMT2A Q03164 2/20 0.35
MTOR P42345 1/20 0.35
KDM4E B2RXH2 3/20 0.35
ESR1 P03372 2/20 0.35
ADRA2A P08913 2/20 0.35
ADORA3 P0DMS8 2/20 0.35
TACR2 P21452 2/20 0.35
SLC6A2 P23975 2/20 0.35
SLC6A4 P31645 2/20 0.35
SLC6A3 Q01959 2/20 0.35
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22011820 0.89 RARB (0.46) RARBABCB1RARARARGHSD17B10
SCHEMBL22010983 0.87 ALDH1A1 (0.38) RARBABCB1RARARARGHSD17B10
SCHEMBL22011800 0.84 HTT (0.37) HSD17B10TSHRALDH1A1MEN1MAPT
SCHEMBL22010955 0.83 RARB (0.40) RARBABCB1RARARARGHSD17B10
SCHEMBL22011234 0.82 CTSL (0.38) TSHRALDH1A1MEN1MAPTKMT2A
SCHEMBL22010835 0.82 RARB (0.40) RARBABCB1RARARARGHSD17B10
SCHEMBL22010821 0.81 RARB (0.36) RARBHSD17B10TSHRALDH1A1MEN1
SCHEMBL22011138 0.80 MAPT (0.37) RARBABCB1RARARARGHSD17B10
SCHEMBL20828855 0.79 ALDH1A1 (0.40) HSD17B10TSHRALDH1A1MEN1MAPT
SCHEMBL22011795 0.79 ALDH1A1 (0.38) HSD17B10TSHRALDH1A1MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10662378-B2 Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2020-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10662378-B2 Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display device YBX1, ZKSCAN2, RCC1 RARB 2226/4885ABCB1 1178/4885RARA 1881/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.